New York Mortgage Trust, Inc. 

(Public, NASDAQ:NYMT)   Watch this stock   
Find more results for NYMT
Nov 4, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 3, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 33.02% -58.39%
Operating margin 33.02% -58.39%
EBITD margin - -9.89%
Return on average assets 1.74% -3.10%
Return on average equity 20.42% -89.36%
Employees 4 -

Address

1301 Avenue of the Americas
New York, NY 10019
United States - Map
+1-212-7920107 (Phone)
+1-212-6349428 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

New York Mortgage Trust, Inc. discussions

  View all discussions »

Description

New York Mortgage Trust, Inc. (NYMT) together with its consolidated subsidiaries is a self-advised real estate investment trust (REIT). The Company invests primarily in real estate-related assets, including residential adjustable-rate mortgage-backed securities, which includes collateralized mortgage obligation floating rate securities (RMBS), and prime credit quality residential adjustable-rate mortgage (ARM) loans (prime ARM loans), and to a lesser extent, in certain alternative real estate-related and financial assets. As of December 31, 2008, its investment portfolio included approximately $197.7 million of collateralized mortgage obligation floating rate securities issued by the Federal National Mortgage Association (Fannie Mae), or the Federal Home Loan Mortgage Corporation (Freddie Mac).

Officers and directors

Steven R. Mumma
President, Chief Executive Officer, Chief Financial Officer
Age: 50
Bio & Compensation - Reuters
James J. Fowler
Non-Executive Chairman of the Board
Age: 47
Bio & Compensation - Reuters
Alan L. Hainey
Independent Director
Age: 63
Bio & Compensation - Reuters
Steven G. Norcutt
Independent Director
Age: 49
Bio & Compensation - Reuters
Steven M. Abreu
Independent Director
Age: 44
Bio & Compensation - Reuters